<DOC>
	<DOCNO>NCT00284713</DOCNO>
	<brief_summary>Intracoronary infusion bone marrow derive progenitor cell LAD patient non ischemic dilate cardiomyopathy .</brief_summary>
	<brief_title>Progenitor Cell Therapy Dilative Cardiomyopathy</brief_title>
	<detailed_description>Initial clinical pilot trial suggest intracoronary infusion bone marrow-derived progenitor cell ( BMC ) may enhance leave ventricular functional recovery patient acute myocardial infarction . It unknown , however , whether strategy might also applicable patient non-ischemic dilate cardiomyopathy ( DCM ) . Therefore , initiate TOPCARE-DCM - trial ( Transplantation Of Progenitor Cells And Recovery Left Ventricular Function Patients non ischemic Dilatative CardioMyopathy ) aim regionally improve leave ventricular contractility selective infusion BMC leave anterior descend coronary artery . Patients randomize 2:1 ( 20/10 ) BMC Infusion versus standard medical therapy</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Age 880 Dilated Cardiomyopathy , Ejection fraction &lt; 40 % LVEDD &gt; 60mm Stable clinical condition within last 6 month Written inform consent Myocardial infarction coronary intervention past Change medical therapy within last 6 week prior cell therapy Tumor within last 5 year incomplete remission Active infection Active bleeding Stroke within last 2 year Surgery trauma within last 2 month Uncontrolled hypertension HIV infection Chronic inflammatory disease Liver disease ( GOT &gt; 2x upper normal limit ) Renal dysfunction ( creatinin &gt; 2.0mg/dl ) Thrombopenia &lt; 100.000 Anemia ( hemoglobin &lt; 8.5 g/dl ) Mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>